Valuation: Guerbet

Market Cap 114M 130M 105M 96.28M 182M 12.5B 186M 1.25B 491M 6.11B 488M 477M 21.05B P/E 2026 *
-253x
P/E 2027 * 5.59x
Enterprise Value 407M 466M 376M 345M 654M 44.8B 665M 4.48B 1.76B 21.9B 1.75B 1.71B 75.47B EV / Sales 2026 *
0.54x
EV / Sales 2027 * 0.49x
Free-Float
36.58%
Yield 2026 *
-
Yield 2027 * 3.89%
1 day-73.78%
1 week+280.98%
Current month+271.67%
1 month+229.88%
3 months+264.38%
6 months+127.55%
Current year+134.90%
1 week 8.73
Extreme 8.73
33.45
1 month 8.73
Extreme 8.73
33.45
Current year 8.1
Extreme 8.1
33.45
1 year 8.1
Extreme 8.1
33.45
3 years 8.1
Extreme 8.1
39.7
5 years 8.1
Extreme 8.1
44.25
10 years 8.1
Extreme 8.1
90.5
Manager TitleAgeSince
Chief Executive Officer - 2026-02-01
Chief Executive Officer - 2025-09-21
Chief Tech/Sci/R&D Officer - -
Director TitleAgeSince
Director/Board Member 44 2015-05-28
Director/Board Member 49 2017-05-18
Director/Board Member 51 2023-11-21
Change 5-day change 1-year change 3-year change Capi.($)
+6.63%+280.98% - - 130M
-1.10%+5.01%-12.69%-21.09% 13.34B
-1.89%-13.40%+57.84%-2.40% 4.39B
+2.50%-2.93%+61.66%+104.62% 1.17B
+3.33%+3.17%-32.66%-60.63% 1.17B
+1.60%+3.85%-37.97%-46.34% 1.1B
+1.62%+3.58%-45.15% - 901M
-1.19%-12.23%+108.81%+109.54% 551M
-2.44%+2.04%+36.17% - 318M
+1.37%+3.82%-52.35%+231.87% 257M
Average -7.00%-0.47%+9.30%+45.08% 2.58B
Weighted average by Cap. -1.01%-2.09%+4.05%-7.79%

Financials

2026 *2027 *
Net sales 754M 862M 695M 639M 1.21B 82.96B 1.23B 8.3B 3.26B 40.55B 3.24B 3.17B 140B 796M 911M 734M 675M 1.28B 87.62B 1.3B 8.77B 3.44B 42.83B 3.42B 3.34B 148B
Net income -1.62M -1.85M -1.49M -1.37M -2.6M -178M -2.64M -17.81M -6.99M -86.99M -6.95M -6.79M -300M 29.08M 33.26M 26.83M 24.66M 46.72M 3.2B 47.52M 320M 126M 1.56B 125M 122M 5.39B
Net Debt 294M 336M 271M 249M 472M 32.3B 480M 3.23B 1.27B 15.79B 1.26B 1.23B 54.42B 277M 317M 256M 235M 446M 30.53B 453M 3.05B 1.2B 14.92B 1.19B 1.17B 51.43B
Logo Guerbet
Guerbet is a European leader in producing and selling contrast products for medical imaging. The group's products make it possible to visualize different organs and the lymphatic and vascular systems of the human body by making them opaque. Net sales break down by product family as follows: - X-ray imaging products (54.4%); - MRI products (32.1%); - other (13.5%): contrast products for echography and nuclear medicine, fine chemicals products. At the end of 2024 the group had 8 production sites located in France (4), the United States (2), Ireland and Brazil. Net sales are distributed geographically as follows: Europe/Middle East/Africa (43.8%), Americas (29.7%) and Asia (26.5%).
Employees
2,700
Date Price Change Volume
26-07-10 €8.750 -0.57% 2
26-07-09 €8.800 +0.23% 0
26-07-07 €8.780 -0.68% 0
Trader
Investor
Global
Quality
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
UNDERPERFORM
Number of Analysts
3
Last Close Price
9.000EUR
Average target price
11.60EUR
Spread / Average Target
+28.89%

Quarterly revenue - Rate of surprise